Trial to Assess Chelation Therapy 2

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
DiabetesMyocardial Infarction
Interventions
DRUG

disodium EDTA

IV Disodium Ethylene diamine tetra acetic acid in 500 cc

DIETARY_SUPPLEMENT

Oral Multi Vitamins/Minerals (OMVM)

6 tablets of Multi-vitamin/Multimineral daily

DRUG

Placebo disodium EDTA

IV Placebo comparator- 500 normal saline

DIETARY_SUPPLEMENT

Placebo Oral Multi Vitamins/Minerals (OMVM)

6 tablets of a placebo Multi-vitamin/Multimineral daily

Trial Locations (1)

33132

Mount Sinai Medical Center, Miami Beach

Sponsors
All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Duke Clinical Research Institute

OTHER

lead

Mt. Sinai Medical Center, Miami

OTHER